Emerging viral infections in transplant recipients

Current Opinion in Infectious Diseases

Volumn 18, Issue 4, 2005, Pages 337-341

  Kumar, Deepali ^a   Humar, Atul ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Immunosuppression; Severe acute respiratory syndrome; Transplantation; West Nile virus

Indexed keywords

ALLOGRAFT; BLOOD TRANSFUSION; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE PREDISPOSITION; ENVIRONMENTAL EXPOSURE; HEALTH CARE SYSTEM; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; INFECTION RISK; NEUROLOGIC DISEASE; ORGAN DONOR; ORGAN TRANSPLANTATION; REVIEW; RISK FACTOR; SARS CORONAVIRUS; SCREENING TEST; SEROPREVALENCE; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS INFECTION; VIRUS LOAD; WEST NILE FLAVIVIRUS;

EID: 22544473063     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qco.0000172697.44784.ff     Document Type: Review

References (22)

1. Petersen LR, Martin AA, Gubler DJ. West Nile virus. JAMA 2003; 290:524-528.
2. Granwehr BP, Lillibridge KM, Higgs S, et al. West Nile virus: where are we now? Lancet Infect Dis 2004; 4:547-556. This recent review provides an update on WNV biology, highlights recent advances in the field and explores several unanswered questions about WNV.
3. Gea-Banacloche J, Johnson RT, Bagic A, et al. West Nile virus: pathogenesis and therapeutic options. Ann Intern Med 2004; 140:545-553.
4. Pealer LN, Martin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003; 349:1236-1245.
5. Iwamoto M, Jernigan DB, Guasch A, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003; 348:2196-2203.
6. The United Network for Organ Sharing (UNOS) under contract with the Health Resources and Services Administration of the US Department of Health and Human Services (HRSA). Organ Procurement and Transplantation Network (OPTN). Available at: www.optn.org. Richmond, Virginia. Accessed: 11 February 2004. This website provides a notice from the HRSA, which provides clarification about available WNV diagnostic and screening tests, and provides guidance for the use of these tests in the setting of organ donation and transplantation.
7. Kiberd BA, Forward K. Screening for West Nile virus in organ transplantation: a medical decision analysis. Am J Transplant 2004; 4:1296-1301. This decision analysis suggested that in many cases screening donors for WNV may be detrimental from a societal perspective because of false-positive screening tests. Screening would be most beneficial in high seroprevalence areas.
8. Kumar D, Prasad GV, Zaltzman J, et al. Community-acquired West Nile virus infection in solid-organ transplant recipients. Transplantation 2004; 77:399-402.
9. Kleinschmidt-DeMasters BK, Marder BA, Levi ME, et al. Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features. Arch Neurol 2004; 61:1210-1220. This case series from Colorado describes the features of 11 transplant recipients with community-acquired WNV. Although the findings are similar to those seen in non-transplant patients, they tend to be at the severe end of the spectrum.
10. Ravindra KV, Freifeld AG, Kalil AC, et al. West Nile virus-associated encephalitis in recipients of renal and pancreas transplants: case series and literature review. Clin Infect Dis 2004; 38:1257-1260; E-published 14 April 2004.
11. Kumar D, Drebot MA, Wong SJ, et al. A seroprevalence study of West Nile virus infection in solid organ transplant recipients. Am J Transplant 2004; 4:1883-1888. By undertaking a seroprevalence study in a transplant population, the risk of neurological disease after infection with WNV was calculated at approximately 40% for transplant patients. This is much higher than the less than 1% risk in the general population. This study also highlighted poor compliance with measures such as insect repellant among transplant patients.
12. Poutanen SM, Low DE. Severe acute respiratory syndrome: an update. Curr Opin Infect Dis 2004; 17:287-294. This recent review provides an update on the virology and epidemiology of SARS.
13. Peiris JS, Yuen KY, Osterhaus AD, Stohr K. The severe acute respiratory syndrome. N Engl J Med 2003; 349:2431-2441.
14. Chinese SARS Molecular Epidemiology Consortium. Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 2004; 303:1666-1669. This paper describes the molecular evolution of the SARS coronavirus.
15. Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003; 289:2801-2809.
16. Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348:1986-1994.
17. Kumar D, Tellier R, Draker R, et al. Severe acute respiratory syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening. Am J Transplant 2003; 3:977-981.
18. Kumar D, Farcas G, Uy K, et al. Severe acute respiratory syndrome (SARS) in transplantation: clinical and virologic findings and implementation of a SARS screening tool [Abstract no. 975] Am J Transplant 2004; 4(Suppl. 8): 425.
19. Lam MF, Ooi GC, Lam B, et al. An indolent case of severe acute respiratory syndrome. Am J Respir Crit Care Med 2004; 169:125-128.
20. Farcas GA, Poutanen SM, Mazzulli T, et al. Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. J Infect Dis 2005; 191:193-197. E-published 10 December 2004. The authors analyse SARS coronavirus viral load in a number of tissues from autopsy specimens of SARS patients. They demonstrate a high copy number of virus spread throughout numerous tissues.
21. Chui AK, Rao AR, Chan HL, Hui AY. Impact of severe acute respiratory syndrome on liver transplantation service. Transplant Proc 2004; 36:2302-2303. In the midst of a SARS outbreak, a liver transplant programme was essentially shut down because of concerns about donors and recipients and as a result of resource issues.
22. Allen U, Hebert D, Churchill C, et al. The potential impact of SARS on organ transplantation: exercise caution. Pediatr Transplant 2003; 7:345-347.